Prithviraj Bose

63PUBLICATIONS
185CO-AUTHORS
HaematologyRegenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Aug 18, 2026
Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Feb 13, 2026
Clinical, genetic, and familial features of POT1 tumor predisposition syndrome.

Courtney D DiNardo, Jennifer Croden, Hiam M Abdel-Salam

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Nov 24, 2025
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.

Monia Marchetti, Alessandro Maria Vannucchi, John O Mascarenhas

Pageof 11

Frequent Collaborators

18 joint publications

Tapan M Kadia

17 joint publications

Courtney DiNardo

17 joint publications

Hagop M Kantarjian

16 joint publications

Naveen Pemmaraju